Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
To study the individual effects of glucagon and growth hormone on human carbohydrate and lipid metabolism, endogenous secretion of both hormones was simultaneously suppressed with somatostatin and physiologic circulating levels of one or the other hormone were reproduced by exogenous infusion. The interaction of these hormones with insulin was evaluated by performing these studies in juvenile-onset, insulin-deficient diabetic subjects both during infusion of insulin and after its withdrawal. Infusion of glucagon (1 ng/kg-min) during suppression of its endogenous secretion with somatostatin produced circulating hormone levels of approximately 200 pg/ml. When glucagon was infused along with insulin, plasma glucose levels rose from 94 +/- 8 to 126 +/- 12 mg/100 ml over 1 h (P less than 0.01); growth hormone, beta-hydroxy-butyrate, alanine, FFA, and glycerol levels did not change. When insulin was withdrawn, plasma glucose, beta-hydroxybutyrate, FFA, and glycerol all rose to higher levels (P less than 0.01) than those observed under similar conditions when somatostatin alone had been infused to suppress glucagon secretion. Thus, under appropriate conditions, physiologic levels of glucagon can stimulate lipolysis and cause hyperketonemia and hyperglycemia in man; insulin antagonizes the lipolytic and ketogenic effects of glucagon more effectively than the hyperglycemic effect. Infusion of growth hormone (1 mug/kg-h) during suppression of its endogenous secretion with somastostatin produced circulating hormone levels of approximately 6 ng/ml. When growth hormone was administered along with insulin, no effects were observed. After insulin was withdrawn, plasma beta-hydroxybutyrate, glycerol, and FFA all rose to higher levels (P less than 0.01) than those observed during infusion of somatostatin alone when growth hormone secretion was suppressed; no difference in plasma glucose, alanine, and glucagon levels was evident. Thus, under appropriate conditions, physiologic levels of growth hormone can augment lipolysis and ketonemia in man, but these actions are ordinarily not apparent in the presence of physiologic levels of insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucagon has also effects on lipid metabolism stimulates lipolysis and hepatic fatty acid oxidation [197] but its effects should be always be considered relative to the insulin levels since insulin exerts opposite effects on lipid metabolism [198].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [198]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Felig, P. (1973) · Metabolism · doi:10.1016/0026-0495(73)90269-2 · Cited by 794
The essential role of glucagon in the pathogenesis of diabetes mellitus
Unger, R., & Orci, L. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92375-2 · Cited by 599
INHIBITION OF INSULIN SECRETION BY SOMATOSTATIN
Alberti, K. G. M. M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., & Ørskov, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92873-0 · Cited by 457
EFFECT OF GROWTH HORMONE ON PLASMA FATTY ACIDS*
Raben, M. S., & Hollenberg, C. H. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103824 · Cited by 445
Gerich, J. E., Lorenzi, M., Bier, D. M., Schneider, V., Tsalikian, E., Karam, J. H., & Forsham, P. H. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505082921901 · Cited by 354
Self-citationGlucagon levels and metabolic effects in fasting man
Marliss, E. B., Aoki, T. T., Unger, R. H., Soeldner, J. S., & Cahill, G. F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106445 · Cited by 339
Fain, J. N., Kovacev, V. P., & Scow, R. O. (1965) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)97175-9 · Cited by 270
Mortimer, C. H., Carr, D., Lind, T., Bloom, S. R., Mallinson, C. N., Schally, A. V., Tunbridge, W. M. G., Yeomans, L., Coy, D. H., Kastin, A., et al. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92903-1 · Cited by 268
Gerich, J. E., Lorenzi, M., Schneider, V., Karam, J. H., Rivier, J., Guillemin, R., & Forsham, P. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197409122911102 · Cited by 239
Self-citationGlucagon: Role in the Hyperglycemia of Diabetes Mellitus
Dobbs, R., Sakurai, H., Sasaki, H., Faloona, G., Valverde, I., Baetens, D., Orci, L., & Unger, R. (1975) · Science · doi:10.1126/science.1089999 · Cited by 229
Research works printed but not linked: 2
- [51]51. Lefebvre, P. 1972. Glucagon and lipid metabolism. In Glucagon: Molecular Physiology, Clinical and Therapeutic Implications. P. Lefebvre and R. H. Unger, editors. Pergamon Press, Inc., Elmsford, N. Y. 109–121.
- [57]57. Davidoff, F. 1968. The disturbances of carbohydrate metabolism in acromegaly—a perspective view, 19271967. Proc. Rudolf Virchow Med. Soc. City N. Y. 26 (Suppl.): 83-115.
Cited by
Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., Barrett, E. J., Kreisberg, R. A., Malone, J. I., & Wall, B. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.131 · Cited by 710
Effect of Growth Hormone on Carbohydrate and Lipid Metabolism
DAVIDSON, M. B. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-115 · Cited by 573
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
Self-citationThe Effect of Growth Hormone on Glucose Metabolism and Insulin Secretion in Man*
BRATUSCH-MARRAIN, P. R., SMITH, D., & DEFRONZO, R. A. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-973 · Cited by 321
Meier, J. J., Nauck, M. A., Pott, A., Heinze, K., Goetze, O., Bulut, K., Schmidt, W. E., Gallwitz, B., & Holst, J. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.004 · Cited by 266
Metadata
- Authors
- Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1976-04-01
- Volume
- 57
- Issue
- 4
- Pages
- 875-884
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC436731
- OpenAlex
- W2003781513
- Cited by
- 198
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 2 · 2014: 2 · 2012: 1
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- glucagon, growth hormone, insulin, somatostatin, carbohydrate metabolism, lipid metabolism, lipolysis, ketogenesis, hyperketonemia, hyperglycemia, insulin deficiency, type 1 diabetes, beta-hydroxybutyrate, free fatty acids, glycerol, alanine, insulin antagonism
- MeSH terms
- Adult, Alanine, Blood Glucose, Depression, Chemical, Diabetes Mellitus, Fatty Acids, Nonesterified, Female, Glucagon, Glycerol, Humans, Hydroxybutyrates, Male, Somatostatin, Growth Hormone, Diabetic Ketoacidosis, Carbohydrate Metabolism, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. https://app.cochat.ai/papers/10.1172/jci108364
- The paper
- Gerich, J. E., Lorenzi, M., Bier, D. M., Tsalikian, E., Schneider, V, Karam, J. H., & Forsham, P. H. (1976). Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. Journal of Clinical Investigation. https://doi.org/10.1172/jci108364
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.